KPV in Australia

KPV is a short tripeptide studied in cellular and inflammation research. This page covers what it is, the research areas it appears in, and how to source it with documentation from Australian stock.

What is KPV?

KPV is a short three-amino-acid peptide (lysine-proline-valine) from the C-terminal sequence of α-MSH, studied in cellular research.

At three amino acids it is the shortest compound in this range — the name is simply the single-letter codes for its three residues: K (lysine), P (proline), V (valine). There is nothing else to it. No cyclic ring, no fatty-acid chain, no stability tail. It is about as structurally simple as a functional peptide gets.

Its origin is the interesting part. α-MSH — alpha-melanocyte-stimulating hormone — is a thirteen-amino-acid hormone best known in the melanocortin system, the same family that Melanotan II and PT-141 belong to. KPV is the final three residues of that sequence. But unlike its melanocortin relatives, it is not studied for receptor-binding activity in the pigmentation pathway. The research interest concerns a different property of the fragment entirely, which is why it sits in a separate category on this site despite sharing a parent molecule.

That's the recurring theme in fragment research: cutting a hormone into pieces doesn't produce three weaker copies of the whole. Different fragments carry different properties, and a fragment can end up in a research field the parent hormone was never associated with.

Research areas

In the scientific literature, KPV is studied in relation to:

• Inflammation research
• Gut and digestive research
• Skin-condition research
• Cellular signalling and epithelial research
• Peptide-fragment structure–activity research

These describe fields of scientific study — they are not claims about effects in humans. Nothing here should be read as a statement about what the compound does in a person; NextGen Peptides supplies it strictly for laboratory and in-vitro research use.

Its extreme simplicity is itself part of why it's studied. A three-amino-acid peptide is cheap to synthesise, easy to characterise, and small enough that its behaviour can be attributed to a very short sequence rather than to complex folded structure. For structure–activity work — establishing which part of a molecule is responsible for which property — a minimal fragment is an unusually clean starting point.

KPV and other cellular-research compounds

Within this category KPV is frequently mentioned alongside GHK-Cu, another very short peptide studied in skin and cellular research. They're worth distinguishing:

• KPV — three amino acids, a fragment of α-MSH, studied around inflammation and epithelial research.
• GHK-Cu — three amino acids plus a bound copper ion, studied largely as a copper-delivery vehicle in collagen and matrix research.

Similar size, entirely different origins and mechanisms. It's also studied alongside the tissue-repair compounds BPC-157 and TB-500, which are likewise fragments of larger parent proteins.

Storage & handling

Supplied as a lyophilised (freeze-dried) powder. Store at −20°C; reconstitute with bacteriostatic water and refrigerate. See our full guide to storing and reconstituting research peptides, and what to mix it with in our bacteriostatic water guide.

Very short peptides are the most forgiving in this range — with only three residues there is minimal folded structure to disrupt, so the denaturing risk that makes long chains fragile barely applies. The basics still hold: run diluent slowly down the vial wall and swirl rather than shake, refrigerate at 2–8°C once mixed, keep vials boxed and out of light, and never refreeze a reconstituted solution. Concentration is determined by how much diluent you add — our reconstitution calculator works it out.

Sourcing KPV in Australia

We hold KPV in Australian stock, so orders placed before the daily cut-off are dispatched same or next business day — no overseas freight, no customs wait. Every batch is independently third-party tested, with the Certificate of Analysis published. New to buying research peptides? Read our Australian buyer’s guide first.

Common questions about KPV

What is KPV?
A short three-amino-acid peptide (lysine-proline-valine) from the C-terminal sequence of α-MSH, studied in cellular research. Supplied for laboratory research use only.

What research areas is KPV studied in?
Inflammation research, gut and digestive research, and skin-condition research. These are fields of study, not effects in humans.

Is KPV tested and does it come with a CoA?
Yes. Every batch is independently tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published.

Is KPV held in Australian stock?
Yes. We hold KPV in Australian stock and dispatch same or next business day for orders placed before the daily cut-off.

Why is it called KPV?
The name is the single-letter codes for its three amino acids — K (lysine), P (proline), V (valine). That's the entire sequence.

If it comes from α-MSH, is it a melanocortin compound?
It shares the parent hormone with Melanotan II and PT-141, but it isn't studied for receptor-binding activity in the pigmentation pathway. Different fragments of a hormone carry different properties, which is why it sits in a separate research category.

How is KPV different from GHK-Cu?
Both are three-amino-acid peptides in cellular research, but they're otherwise unrelated. GHK-Cu carries a bound copper ion and is studied largely as a copper-delivery vehicle; KPV has no metal component and comes from a different parent molecule.

How long does a reconstituted vial last?
Generally around four weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Unreconstituted powder at −20°C keeps far longer. Never refreeze a reconstituted solution.

Does it need cold-chain shipping?
No. Lyophilised powder is stable in transit. Orders ship from Melbourne in discreet, unmarked packaging with tracking — see shipping & delivery.

Legal status and intended use

KPV is supplied by NextGen Peptides strictly as a research chemical for laboratory and in-vitro use. It is not an approved therapeutic good in Australia, it is not supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over. For the regulatory framework, see our guide to the legal status of research peptides in Australia.

Related research

Explore related compounds held in Australian stock: GHK-Cu and BPC-157.

Shop KPV

Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.